Potential Health Problems Linked to Ozempic, Wegovy, and Other Weight Loss Drugs Recent studies and reports highlight that Ozempic, Wegovy, and other GLP-1 receptor agonist drugs are associated with serious health risks, including stomach paralysis, also known as gastroparesis, as well as other gastrointestinal issues
The team will study the effects of GLP-1 drugs on five disproportionately burdened populations: racially minoritized groups, individuals of low socioeconomic status, rural and non-metro populations, people living with disabilities, and sexual and gender minorities
PlexusDx sources compounded semaglutide from licensed 503A pharmacies and eliminates markup costs, offering treatment at just $189/month with flat pricing regardless of dose
10.1002/oby.24229 7 DaniilopoulouI.VlachouE.LambrouG
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double-blind, randomized, placebo-controlled trial argeting negative symptoms